Two new US Patents to Australian Life Science companies

215 Life Science patents (classification A61K) were issued by the US Patent and Trademark Office on Tuesday 30 August 2016 (click here), Two of them went to Australian assignees.

US Patent 9,427,443 has been granted to the animal health company Jurox Pty Ltd for a formulation of the anesthetic alfaxalone that can be administered parenterally without invoking a histamine response.

US Patent 9,428,587 has been granted to the privately held Sydney cancer antibody company Biosceptre for  antibodies to P2X7 receptors which, when expressed on cells without their usual function ion channel function, is indicative of cancer cells.